Analyst firms · Needham · PSNL
Needham PSNL price target and rating history
Personalis Inc. (PSNL) · Health Care
Needham rates Personalis Inc. (PSNL) Buy with a $8 price target, as of its latest action on Feb 6, 2023. It has published 4 rating actions on PSNL since September 2021, including 2 upgrades and 1 downgrade.
- Current rating
- Buy
- Price target
- $8
- Median target, all firms
- Too few
- Actions on PSNL
- 4
Needham price target on PSNL
Every Needham rating on PSNL
- Feb 6, 2023
- Feb 6, 2023
- Nov 3, 2021DowngradeNeedham downgrades to Hold from Buy
- Sep 20, 2021
How other firms rate PSNL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BTIG | Neutral | Oct 6, 2026 | |
| Craig-Hallum | Hold | $16.25 | Aug 24, 2026 |
| Morgan Stanley | Equal-Weight | $11 | Dec 2, 2025 |
Questions about Needham and PSNL
- What is Needham's price target for PSNL?
- Needham's latest stated price target for Personalis Inc. (PSNL) is $8, from its action on Feb 6, 2023.
- What is Needham's rating on PSNL?
- Needham rates PSNL Buy, a bullish rating, as of Feb 6, 2023.
- When did Needham last change its view on PSNL?
- On Feb 6, 2023, Needham upgrades to Buy from Hold, price target $8.
More PSNL rating histories
All Needham ratingsPSNL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.